Jennifer Trieu
Melbourne, VIC 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
FcRn: A novel target to attenuate rheumatoid cachexia in arthritic mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 02, 2025
Intrinsic muscle stem cell dysfunction underlies functional deficits in models of type 1 diabetes.
Journal: NPJ Regenerative medicine
Published: July 06, 2025
Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia.
Journal: Life sciences
Published: October 24, 2024
Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles.
Journal: Physiological reports
Published: April 08, 2024
The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy.
Journal: Disease models & mechanisms
Published: September 10, 2023
Sulforaphane attenuates cancer cell-induced atrophy of C2C12 myotubes.
Journal: American journal of physiology. Cell physiology
Published: December 19, 2022
Dystrophin deficiency disrupts muscle clock expression and mitochondrial quality control in mdx mice.
Journal: American journal of physiology. Cell physiology
Published: June 30, 2021
Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 15, 2021
Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy.
Journal: American journal of physiology. Cell physiology
Published: March 17, 2021
Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling.
Journal: Frontiers in nutrition
Published: July 12, 2019
Last Updated: 09/26/2026